Zymeworks Inc.

For the period ended Mar 31, 2026. Filed May 7, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 7, 2026

ZYME$30.81+4.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Balance Sheets

(In thousands except share data)

	March 31,2026	December 31,2025
Assets · (unaudited)
Current assets:
Cash and cash equivalents	$244,282	$41,157
Short-term marketable securities	120,445	187,640
Accounts receivable	4,674	4,638
Prepaid expenses and other current assets	16,279	15,332
Total current assets	385,680	248,767
Long-term marketable securities	39,116	41,787
Long-term prepaids and other assets	6,652	6,674
Deferred tax asset	4,707	4,707
Property and equipment, net	14,854	15,502
Operating lease right-of-use assets	14,016	15,724
Intangible assets, net	1,174	1,350
Goodwill	12,016	12,016
Total assets	$478,215	$346,527
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable and accrued liabilities	$30,226	$36,346
Income tax payable	66	83
Current portion of operating lease liability	3,279	3,471
Deferred revenue	2,078	2,418
Total current liabilities	35,649	42,318
Long-term portion of operating lease liability	13,763	14,796
Deferred revenue	14,606	14,606
Liability related to sale of future royalties	246,503	—
Other long-term liabilities	278	278
Deferred tax liability	3,827	6,028
Total liabilities	314,626	78,026
Stockholders’ equity:
Common stock, $0.00001 par value; 900,000,000 authorized shares at March 31, 2026 and December 31, 2025, respectively; 73,102,689 and 74,638,413 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively	1,128,553	1,105,176
Preferred shares, $0.00001 par value; 100,000,000 authorized shares of preferred stock, out of which, one share of preferred stock is a share of Special Voting Preferred Stock and outstanding as of March 31, 2026 and December 31, 2025	—	—
Exchangeable shares, no par value, 550,884 and 553,184 issued and outstanding shares at March 31, 2026 and December 31, 2025, respectively	7,905	7,938
Additional paid-in capital	107,530	114,626
Accumulated other comprehensive loss	(6,565)	(6,079)
Accumulated deficit	(1,073,834)	(953,160)
Total stockholders’ equity	163,589	268,501
Total liabilities and stockholders’ equity	$478,215	$346,527

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.